Goodwin Procter LLP advised Pear Therapeutics on the deal. Pear Therapeutics announced its definitive business combination agreement with Thimble Point Acquisition Corp. (Nasdaq: THMA), a special purpose […]
Pear Therapeutics’ $1.6 Billion Business Combination with Thimble Point Acquisition Corp.
Cambridge Mobile Telematics’ Acquisition of TrueMotion
Goodwin Procter LLP advised TrueMotion on the deal. TrueMotion announced its acquisition by Cambridge Mobile Telematics. The transaction, which closed on June 16, unites the two leading […]
Merryfield’s Strategic, Promotional and Co-founder Relationship with Zooey Deschanel
Goodwin Procter LLP advised Merryfield on the deal. Merryfield, a new app, loyalty program and trusted authority on better-for-you, purpose-led brands like Stonyfield Organic, ECOS, Orgain, […]
Aerpio Pharmaceuticals’ Merger with Aadi Bioscience
Wilson Sonsini Goodrich & Rosati advised Aadi Bioscience on the deal while Goodwin Procter LLP represented Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals and Aadi Bioscience announced their […]
Privia Health Group’s $607.8 IPO
Goodwin Procter LLP advised the underwriters on the deal. Privia Health Group, Inc. (“Privia Health”) (Nasdaq: PRVA), a technology-driven, national physician enablement company that collaborates with […]
CompoSecure’s Merger With Roman DBDR Tech Acquisition
Goodwin Procter LLP advised Roman DBDR, while Morgan, Lewis & Bockius LLP advised CompoSecure on the deal. Simpson Thacher served as counsel to the placement agents. […]
Tango Therapeutics’ $353 Million Merger with BCTG Acquisition Corp.
Goodwin Procter LLP advised Tango Therapeutics on the deal while Wilson Sonsini Goodrich & Rosati represented BCTG Acquisition Corp. Tango Therapeutics announced its definitive merger agreement with […]
Olink Holding AB’s $264.7 Million IPO
Goodwin Procter LLP and Advokatfirman Delphi advised Olink Holding AB on the deal, while Baker McKenzie legal advisor to minority selling shareholders. Sweden-based Olink Holding AB […]
Rubius Therapeutics’ $200 Million Underwritten Public Offering
Goodwin Procter LLP advised Rubius Therapeutics on the deal. Rubius Therapeutics (NASDAQ: RUBY) announced the upsized underwritten public offering of 6,896,552 shares of its common stock at […]
Markforged’s Merge With One
Goodwin Procter LLP advised Markforged on the deal, while Cadwalader advised One.Markforged announced its definitive agreement to merge with One (NYSE: AONE), a special purpose acquisition company […]
Alpha Healthcare Acquisition Corp.’s $ 1.1 Billion Business Combination With Humacyte, Inc.
Goodwin Procter LLP advised Alpha Healthcare Acquisition Corp. on the deal. Covington & Burling LLP advised Humacyte, Inc. on the deal.Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) […]
TPG Pace Tech Opportunities’ Business Combination With Nerdy
Vinson & Elkins LLP advised TPG Pace Tech Opportunities on the deal while Goodwin Procter LLP advised Nerdy Inc. on the deal. TPG Pace Tech Opportunities […]